ARWR  valuation analysis

Basics
Name: Arrowhead Pharmaceuticals, Inc
Description: Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 04, 2021
Market cap: $6.57B (614th)
Sales(TTM): $89.12M (1401st)
Earnings(TTM): -$109.59M (1266th)

Value
FFER: 4.43 (why)
Actual price: $63.15
FFEThis is Arrowhead Pharmaceuticals, Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $14.26
Quantile: ARWR is very expensive given its fundamentals.
Prices as of EOD 2021-07-15
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • Arrowhead Pharmaceuticals, Inc's earnings decreased from $9.53M to -$109.59M in the last year.
  • Arrowhead Pharmaceuticals, Inc's operating income decreased from $1.14M to -$118.35M in the last year.
Earnings / MarketCap
Arrowhead Pharmaceuticals, Inc
"Biotechnology" industry
Sales / MarketCap
Arrowhead Pharmaceuticals, Inc
"Biotechnology" industry
Book / MarketCap
Arrowhead Pharmaceuticals, Inc
"Biotechnology" industry
Equity / Assets
Arrowhead Pharmaceuticals, Inc
"Biotechnology" industry